$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| US FDA APPROVES EXPANDED INDICATION FOR BRILINTA | 04 Sep 2015 |
| ASTRAZENECA AND VALEANT TO PARTNER ON BRODALUMAB | 01 Sep 2015 |
| TOTAL VOTING RIGHTS | 01 Sep 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 28 Aug 2015 |
| ASTRAZENECA APPOINTS DR SEAN BOHEN | 24 Aug 2015 |
| TOTAL VOTING RIGHTS | 03 Aug 2015 |
| HALF YEARLY REPORT | 30 Jul 2015 |
| NOTICE OF RESULTS | 29 Jul 2015 |
| CONFIRMATION OF CHANGE IN ADS RATIO | 27 Jul 2015 |
| ASTRAZENECA AGREEMENT WITH GENZYME ON CAPRELSA | 27 Jul 2015 |
| AZ COMPLETES AGREEMENT WITH TILLOTTS FOR ENTOCORT | 17 Jul 2015 |
| HOLDING(S) IN COMPANY | 17 Jul 2015 |
| IRESSA APPROVED BY US FDA | 14 Jul 2015 |
| AGREEMENT WITH TILLOTTS ON ENTOCORT | 09 Jul 2015 |
| TOTAL VOTING RIGHTS | 01 Jul 2015 |
| CHANGE IN ADS RATIO | 26 Jun 2015 |
| PUBLICATION OF PROSPECTUS | 25 Jun 2015 |
| DIRECTOR/PDMR SHAREHOLDING | 16 Jun 2015 |
| HOLDING(S) IN COMPANY | 03 Jun 2015 |
| TOTAL VOTING RIGHTS | 01 Jun 2015 |
